Gestational trophoblastic disease II: Classification and management of gestational trophoblastic neoplasia

American Journal of Obstetrics and Gynecology

Volumn 204, Issue 1, 2011, Pages 11-18

  Lurain, John R ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

chemotherapy; choriocarcinoma; gestational trophoblastic disease; gestational trophoblastic neoplasia

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; HYDROXYUREA; IFOSFAMIDE; METHOTREXATE; PACLITAXEL; PLATINUM; VINCRISTINE;

ALOPECIA; CANCER RISK; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DRUG MEGADOSE; FOLLOW UP; GESTATIONAL AGE; HUMAN; HYSTERECTOMY; METASTASIS; MULTIMODALITY CANCER THERAPY; NAUSEA; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE; STOMATITIS; SURVIVAL RATE; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT FAILURE; TROPHOBLASTIC TUMOR; WORLD HEALTH ORGANIZATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHORIONIC GONADOTROPIN; DACTINOMYCIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; HYSTERECTOMY; LEUCOVORIN; METHOTREXATE; NEOPLASM STAGING; PREGNANCY; REMISSION INDUCTION; TREATMENT FAILURE; TUMOR MARKERS, BIOLOGICAL;

EID: 78650707087     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2010.06.072     Document Type: Review

References (91)

1. J.R. Lurain Treatment of gestational trophoblastic tumors Curr Treat Options Oncol 3 2002 113 124
2. S. Ngan, and M.J. Seckl Gestational trophoblastic neoplasia management: an update Curr Opin Oncol 19 2007 486 491
3. J.T. Soper Gestational trophoblastic disease Obstet Gynecol 108 2006 176 187
4. R.S. Berkowitz, and D.P. Goldstein Current management of gestational trophoblastic disease Gynecol Oncol 112 2009 654 662
5. J.B. Schlaerth, C.P. Morrow, and M. Rodriguez Diagnostic and therapeutic curettage in gestational trophoblastic disease Am J Obstet Gynecol 162 1990 1465 1470
6. M. Pezeshki, B.W. Hancock, and P. Silcocks The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease Gynecol Oncol 95 2004 423 429
7. N.E. van Trommel, L.F. Massuger, and R.H. Verheijen The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort study Gynecol Oncol 99 2005 6 13
8. E.I. Garner, C.M. Feltmate, D.P. Goldstein, and R.S. Berkowitz The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort study Gynecol Oncol 99 2005 3 5
9. H.Y.S. Ngan, H. Bender, and J.L. Benedet Gestational trophoblastic neoplasia, FIGO staging and classification Int J Gynecol Obstet 83 2003 175 177
10. J.R. Lurain, L.A. Casanova, D.S. Miller, and A.W. Rademaker Prognostic factors in gestational trophoblastic tumors: a proposed new scoring system based on multivariate analysis Am J Obstet Gynecol 164 1991 611 616
11. J.R. Lurain Pharmacotherapy of gestational trophoblastic disease Expert Opin Pharmacother 4 2003 1 13
12. M. Alazzam, J. Tidy, B.W. Hancock, and R. Osborne First line chemotherapy in low risk gestational trophoblastic neoplasia Cochrane Database Syst Rev 1 2009 CD007102
13. C.B. Hammond, R. Hertz, and G.T. Ross Primary chemotherapy for nonmetastatic gestational trophoblastic neoplasms Am J Obstet Gynecol 98 1967 71 78
14. C.B. Hammond, L.G. Borchert, and L. Tyrey Treatment of metastatic trophoblastic disease: good and poor prognosis Am J Obstet Gynecol 115 1973 451 457
15. J.R. Lurain, and E.P. Elfstrand Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors Am J Obstet Gynecol 172 1995 574 579
16. K.D. Bagshawe, J. Dent, and E.S. Newlands The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumors Br J Obstet Gynecol 96 1989 795 802
17. A.P. Garrett, E.O. Garner, and D.P. Goldstein Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors J Reprod Med 47 2002 355 362
18. R.S. Berkowitz, D.S. Goldstein, and M.R. Bernstein Ten years' experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease Gynecol Oncol 23 1986 111 118
19. L.C. Wong, Y.C. Choo, and H.K. Ma Methotrexate with citrovorum factor rescue in gestational trophoblastic disease Am J Obstet Gynecol 152 1985 59 62
20. I.A. McNeish, S. Strickland, and L. Holden Low-risk persistent gestational trophoblastic disease: outcome following initial treatment with low-dose methotrexate and folinic acid, 1992-2000 J Clin Oncol 20 2002 1838 1844
21. F. Khan, J. Everand, and S. Ahmed Low-risk persistent trophoblastic disease treated with low-dose methotrexate: efficacy and long term effects Br J Cancer 89 2003 2197 2201
22. W.B. Growden, A.J. Wolfberg, and D.P. Goldstein Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia Gynecol Oncol 112 2009 353 357
23. R.S. Berkowitz, D.P. Goldstein, and M.R. Bernstein Methotrexate infusion with folinic acid in primary therapy of nonmetastatic trophoblastic tumors Gynecol Oncol 36 1990 56 59
24. L. Elit, A. Covens, and R. Osborne High-dose methotrexate for gestational trophoblastic disease Gynecol Oncol 54 1994 282 287
25. L.C. Wong, H.Y.S. Ngan, and D.K.L. Cheng Methotrexate infusion in low-risk gestational trophoblastic disease Am J Obstet Gynecol 183 2000 1579 1582
26. H.D. Homesley, J.A. Blessing, and M. Rettenmaier Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease Obstet Gynecol 72 1988 413 418
27. H.D. Homesley, J.A. Blessing, and J. Schlaerth Rapid escalation of weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease: a gynecologic oncology group study Gynecol Oncol 39 1990 305 308
28. M.S. Hoffman, J.V. Fiorica, and N.C. Gleeson A single institution experience with weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease Gynecol Oncol 60 1996 292 294
29. R. Osathanondh, D.P. Goldstein, and G.B. Pastorfide Actinomycin D as the primary agent for gestational trophoblastic disease Cancer 36 1975 863 866
30. E.S. Petrilli, and C.P. Morrow Actinomycin D toxicity in the treatment of trophoblastic disease: a comparison of the 5-day course to single-dose administration Gynecol Oncol 9 1980 18 22
31. E.I. Kohorn Is lack of response to single-agent chemotherapy in gestational trophoblastic disease associated with dose scheduling or chemotherapy resistance Gynecol Oncol 85 2002 36 39
32. L.B. Twiggs Pulse actinomycin D scheduling in nonmetastatic gestational trophoblastic neoplasia: cost-effective chemotherapy Gynecol Oncol 16 1982 190 195
33. J.B. Schlaerth, C.P. Morrow, and R.H. Nalick Single-dose actinomycin D in the treatment of postmolar trophoblastic disease Gynecol Oncol 19 1984 53 56
34. E.S. Petrilli, L.B. Twiggs, and J.A. Blessing Single-dose actinomycin D treatment for nonmetastatic gestational trophoblastic disease Cancer 60 1987 2173 2176
35. M.M. Gilani, F. Yarandi, and Z. Eftekhar Comparison of pulse methotrexate and pulse actinomycin D in the treatment of low-risk gestational trophoblastic neoplasia Aust N Z J Obstet Gynecol 45 2005 161 164
36. F. Yarandi, Z. Eftekhar, and H. Shojaei Pulse methotrexate versus pulse actinomycin D in the treatment of low-risk gestational trophoblastic neoplasia Int J Gynecol Obstet 103 2008 33 37
37. R. Osborne, M. Filiaci, and J. Schink A randomized phase III trial comparing weekly parenteral methotrexate and "pulsed" actinomycin as primary management for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study Gynecol Oncol 108 2008 52
38. E.B. Smith, J.C. Weed Jr, and L. Tyrey Treatment of nonmetastatic gestational trophoblastic disease: results of methotrexate alone versus methotrexate-folinic acid Am J Obstet Gynecol 144 1982 88 92
39. N.C. Gleeson, M.A. Finan, and J.V. Fiorica Nonmetastatic gestational trophoblastic disease: weekly methotrexate compared with 8-day methotrexate-folinic acid Eur J Gynecol Oncol 14 1993 461 465
40. A.A. Lertkhachonsuk, N. Israngura, and S. Wilailak Actinomycin D versus methotrexate-folinic acid as the treatment of stage I, low-risk gestational trophoblastic neoplasia: a randomized controlled trial Int J Gynecol Cancer 19 2009 985 988
41. E.I. Kohorn Decision making for chemotherapy administration in patients with low-risk gestational trophoblastic neoplasia Int J Gynecol Cancer 6 1996 279 285
42. R.A. Abrao, J.M. de Andrade, and D.G. Tiezzi Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactinomycin and combination regimens Gynecol Oncol 108 2008 149 153
43. B. DuBeshter, R.S. Berkowitz, and D.P. Goldstein Management of low-risk gestational trophoblastic tumors J Reprod Med 36 1991 36 39
44. J.T. Soper, D.L. Clarke-Pearson, and A. Berchuck Five-day methotrexate for women with metastatic gestational trophoblastic disease Gynecol Oncol 54 1994 76 79
45. J.P. Roberts, and J.R. Lurain Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy Am J Obstet Gynecol 174 1996 1917 1924
46. A.V. Hoekstra, J.R. Lurain, and A.W. Rademaker Gestational trophoblastic neoplasia: treatment outcomes Obstet Gynecol 112 2008 251 258
47. J.R. Lurain, and J.I. Brewer Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D and cyclophosphamide chemotherapy Obstet Gynecol 65 1985 830 834
48. R.H.J. Begent, and K.D. Bagshawe The management of high-risk choriocarcinoma Semin Oncol 9 1982 198 203
49. S.L. Curry, J.A. Blessing, and P.J. DiSaia A prospective randomized comparison of methotrexate, actinomycin D and chlorambucil (MAC) versus modified Bagshawe regimen in "poor prognosis" gestational trophoblastic disease Obstet Gynecol 73 1989 357 362
50. E.S. Newlands, K.D. Bagshawe, and R.J.H. Begent Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high-risk gestational trophoblastic tumors (1979-1989) Br J Obstet Gynecol 98 1991 550 557
51. G. Bolis, C. Bonazzi, and F. Landoni EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT) Gynecol Oncol 31 1988 439 444
52. M. Bower, E.S. Newlands, and L. Holden EMA/CO for high-risk gestational trophoblastic disease: results from a cohort of 272 patients J Clin Oncol 15 1997 2636 2643
53. S.J. Kim, S.N. Bae, and J.H. Kim Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen Gynecol Oncol 71 1998 247 253
54. H. Matsui, K. Suzuka, and Y. Iitsuka Combination therapy with methotrexate, etoposide and actinomycin D for high-risk gestational trophoblastic tumors Gynecol Oncol 78 2000 28 31
55. P.F. Escobar, J.R. Lurain, and D.K. Singh Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy Gynecol Oncol 91 2003 552 557
56. J.R. Lurain, D.K. Singh, and J.C. Schink Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy J Reprod Med 51 2006 767 772
57. T. Turan, O. Karacay, and G. Tulunay Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia Int J Gynecol Cancer 16 2006 1432 1438
58. W.G. Lu, F. Ye, and Y.M. Shen EMA-CO chemotherapy for high-risk gestational trophoblastic neoplasia: a clinical analysis of 54 patients Int J Gynecol Cancer 18 2008 357 362
59. A.C. Evans Jr, J.T. Soper, and D.L. Clarke-Pearson Gestational trophoblastic disease metastatic to the central nervous system Gynecol Oncol 59 1995 226 230
60. W. Small Jr, J.R. Lurain, and R.M. Shetty Gestational trophoblastic disease metastatic to the brain Radiology 200 1996 277 280
61. G.J. Rustin, E.S. Newlands, and R.H. Begent Weekly alternating etoposide, methotrexate and actinomycin D/vincristine and cyclophosphamide chemotherapy for treatment of CNS metastases of choriocarcinoma J Clin Oncol 7 1989 900 904
62. Y. Bakri, R.S. Berkowitz, and D.P. Goldstein Brain metastases in gestational trophoblastic tumor J Reprod Med 39 1994 179 184
63. E.S. Newlands, L. Holden, and M.J. Seckl Management of brain metastases in patients with high-risk gestational trophoblastic tumors J Reprod Med 47 2002 465 471
64. D.G. Mutch, J.T. Soper, and C.J. Babcock Recurrent gestational trophoblastic disease Cancer 66 1990 978 982
65. N. Pisal, C. North, and J. Tidy Role of hysterectomy in the management of gestational trophoblastic disease Gynecol Oncol 87 2002 190 192
66. E.S. Newlands, M. Bower, and L. Holden Management of resistant gestational trophoblastic tumors J Reprod Med 43 1998 111 118 (Pubitemid 28103574)
67. Y. Tomada, Y. Arii, and S. Kaseki Surgical indications for resection of pulmonary metastases of choriocarcinoma Cancer 46 1980 2723 2730
68. L.-T. Xu, C.-F. Sun, and Y.-E. Wang Resection of pulmonary metastatic choriocarcinoma in 43 drug-resistant patients Ann Thorac Surg 39 1985 257 259
69. K. Saito, K. Harado, and H. Nakayama Role of thoracotomy in pulmonary metastases from gestational choriocarcinoma J Thorac Cardiovasc Surg 85 1983 815 820
70. J.R. Lurain, D.K. Singh, and J.C. Schink The role of surgery in the management of high-risk gestational trophoblastic neoplasia J Reprod Med 51 2006 773 776
71. R.L. Vogelzang, A.A. Nemcek, and Z. Skrtic Uterine arteriovenous malformations: primary treatment with therapeutic embolization J Vasc Interv Radiol 2 1991 517 522
72. A.K. Lim, R. Agarwal, and M.J. Seckl Embolization of bleeding residual uterine vascular malformations in patient with treated gestational trophoblastic tumors Radiology 222 2002 640 644
73. E.L. Fleming, L.A. Garrett, and W.B. Growden The changing role of thoracotomy in gestational trophoblastic neoplasia at the New England Trophoblastic Disease Center J Reprod Med 53 2008 493 498
74. M. Alazzam, B.W. Hancock, and J. Tidy Role of hysterectomy in managing persistent gestational trophoblastic disease J Reprod Med 53 2008 519 524
75. D. Doumplis, K. Al-Khatib, and K. Sieunarine A review of the management by hysterectomy of 25 cases of gestational trophoblastic tumors from March 1993 to January 2006 Br J Obstet Gynecol 114 2007 1168 1171
76. J.R. Lurain, and B. Nejad Secondary chemotherapy for high-risk gestational trophoblastic neoplasia Gynecol Oncol 97 2005 618 623
77. J. Yang, Y. Xiang, and X. Wan Recurrent gestational trophoblastic tumor: management and risk factors for recurrence Gynecol Oncol 103 2006 587 590 (Pubitemid 44602173)
78. H.Y. Ngan, K.F. Tam, and K.W. Lam Relapsed gestational trophoblastic neoplasia: a 20-year experience J Reprod Med 51 2006 829 834
79. Y. Powles, P.M. Savage, and J. Stebbing A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia Br J Cancer 96 2007 732 737
80. Y. Mao, X. Wan, W. Lv, and X. Xie Relapsed or refractory gestational trophoblastic neoplasia treated with etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen Int J Gynecol Obstet 98 2007 44 47
81. E.S. Newlands, P.J. Mulholland, and L. Holden Etoposide and cisplatin/etoposide, methotrexate and actinomycin D (EMA) for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine and patients presenting with metastatic placental site trophoblastic tumors J Clin Oncol 18 2000 854 859
82. J. Wang, D. Short, and N.J. Sebire Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE) Ann Oncol 19 2008 1578 1583
83. A.J. Papadopoulos, M. Foskett, and M.J. Seckl Twenty-five years clinical experience with placental site trophoblastic tumors J Reprod Med 47 2002 460 464
84. A. Hassadia, A. Gillespie, and J. Tidy Placental site trophoblastic tumor: clinical features and management Gynecol Oncol 99 2005 603 607
85. P. Schmid, Y. Nagai, and R. Agarwal Prognostic markers and long-term outcome of placental-site trophoblastic tumors: a retrospective observational study Lancet 374 2009 48 55
86. E.I. Kohorn Regional centers for trophoblastic disease Am J Obstet Gynecol 196 2007 95 96
87. J.R. Lurain, A.V. Hoekstra, and J.C. Schink Results of treatment of patients with gestational trophoblastic neoplasia referred to the Brewer Trophoblastic Disease Center after failure of treatment elsewhere (1979-2006) J Reprod Med 53 2008 535 540
88. R.P. Woolas, M. Bower, and E.S. Newlands Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome Br J Obstet Gynecol 105 1998 1032 1035
89. H. Matsui, Y. Iitsuka, and K. Suzuka Early pregnancy outcomes after chemotherapy for gestational trophoblastic tumor J Reprod Med 49 2004 531 534
90. L.A. Garrett, E.I. Garner, and C.M. Feltmate Subsequent pregnancy outcomes in patients with molar pregnancy and persistent gestational trophoblastic neoplasia J Reprod Med 53 2008 481 486
91. G.J.S. Rustin, E.S. Newlands, and J.-M. Lutz Combination but not single agent methotrexate chemotherapy for gestational trophoblastic tumors (GTT) increases the incidence of second tumors J Clin Oncol 14 1996 2769 2773